Scynexis (SCYX) Current Assets (2013 - 2026)
Scynexis (SCYX) posted Current Assets of $62.7 million for Q1 2026, up 55.28% on a QoQ basis from $40.4 million in Q4 2025, and up 20.05% year-over-year from $52.2 million in Q1 2025.
Scynexis (SCYX) Current Assets (2013 - 2026) Analysis & Trends
Scynexis' Current Assets history runs 14 years deep, the most recent figure standing at $62.7 million for Q1 2026.
- Quarterly Current Assets rose 20.05% year-over-year to $62.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.7 million (up 20.05% YoY) and the FY2025 annual result came in at $40.4 million, down 44.07% from the prior year.
- Current Assets was $62.7 million for Q1 2026 at Scynexis, up from $40.4 million in the prior quarter.
- Across five years, Current Assets topped out at $145.5 million in Q2 2023 and bottomed at $40.4 million in Q4 2025.
- A 5-year average of $85.6 million and a median of $80.5 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets jumped 70.12% — and 2025, when it plunged 48.64%.
- Scynexis' Current Assets stood at $79.1 million in 2022, then gained by 29.16% to $102.1 million in 2023, then slipped by 29.31% to $72.2 million in 2024, then plunged by 44.07% to $40.4 million in 2025, then jumped by 55.28% to $62.7 million in 2026.
- Business Quant data shows SCYX's Current Assets at $62.7 million in Q1 2026, $40.4 million in Q4 2025, and $48.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 62.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.69 Mn |
| Dec 31, 2025 | 40.37 Mn |
| Sep 30, 2025 | 48.69 Mn |
| Jun 30, 2025 | 56.50 Mn |
| Mar 31, 2025 | 52.22 Mn |
| Dec 31, 2024 | 72.18 Mn |
| Sep 30, 2024 | 80.46 Mn |
| Jun 30, 2024 | 94.58 Mn |
| Mar 31, 2024 | 101.67 Mn |
| Dec 31, 2023 | 102.12 Mn |
| Sep 30, 2023 | 128.64 Mn |
| Jun 30, 2023 | 145.53 Mn |
| Mar 31, 2023 | 59.77 Mn |
| Dec 31, 2022 | 79.06 Mn |
| Sep 30, 2022 | 103.57 Mn |
| Jun 30, 2022 | 125.68 Mn |
| Mar 31, 2022 | 101.91 Mn |
| Dec 31, 2021 | 109.38 Mn |
| Sep 30, 2021 | 103.93 Mn |
| Jun 30, 2021 | 115.63 Mn |